Redhill Biopharma
RDHL
#10211
Rank
โ‚น0.35 B
Marketcap
โ‚น273.16
Share price
-5.14%
Change (1 day)
-76.57%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2023 (TTM): โ‚น0.96 Billion

According to Redhill Biopharma's latest financial reports the company's current earnings are โ‚น35.74 Million. In 2022 the company made an earning of -โ‚น6.24 Billion, an increase over its 2021 earnings that were of -โ‚น8.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) โ‚น0.96 B-115.55%
2022 -โ‚น6.24 Billion-26.68%
2021 -โ‚น8.51 Billion28.32%
2020 -โ‚น6.63 Billion80.06%
2019 -โ‚น3.69 Billion8.97%
2018 -โ‚น3.38 Billion-14.76%
2017 -โ‚น3.97 Billion55.07%
2016 -โ‚น2.56 Billion39.26%
2015 -โ‚น1.84 Billion96.9%
2014 -โ‚น0.94 Billion0.78%
2013 -โ‚น0.93 Billion16.93%
2012 -โ‚น0.8 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น690.90 B 68,531.52%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1.302 T 129,289.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น362.84 B 35,942.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น3.80 B 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-โ‚น24.54 Billion-2,536.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel